Cancer Research
Researchers from the United States provide details of new studies and findings in the area of cancer
Published in Gene Therapy Weekly, November 2nd, 2006
Study 1: According to recent research from the United States, adenoviral p53 gene therapy is promising for cancer.
"Mutations in the p53 gene are the most frequent genetic alterations in human tumours, occurring in approximately 50% of all cancers. The p53 protein is pivotal in maintaining genetic integrity after DNA damage, and alterations in the p53 pathway, including mutations in the p53 gene, greatly increase the probability of tumor formation," wrote D.I. Gabrilovich and colleagues, University of Southern Florida.
"Gene therapy using adenoviral p53 has emerged...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-11-02)
More Articles from Gene Therapy Weekly
- Apoptosis
Apoptosis differentially regulated by gene overexpression - Cancer Therapy
Adenovirus vector use eliminates an established tumor - Cardiology
Myotonic dystrophy involves RNA toxicity and cardiac conduction defects - Gene Targeting
Conventional gene targeting protocols lead to loss of targeted cells - Genetics & Genomics
Human artificial chromosomes are stably maintained in mitosis - Acute Myeloid Leukemia Cell Biology
Research from Children's Cancer Research Institute provides new data on acute myeloid leukemia cell biology - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
